What is NSF/NFD?
Neprhrogenic systemic fibrosis (NSF) / Nephrogenic Fibrosing Dermopathy (NFD) is an emerging systemic disorder characterized by widespread tissue fibrosis. NFS/NFD was not known to the medical community before March 1997 and some medical authors suggest that the sudden occurrence of the disease in the last 8 years makes it likely that a new agent or technique of examination causes it. Currently, there is no effective treatment available for NSF/NFD. Based on recent research, NSF/NFD occurs only in patients with advanced or in end stage kidney disease and is strongly related to the use of gadolinium dyes for MRI scans. At this time, there are no known cases of NSF/NFD in patients with normal kidney function. Currently, little is known about NSF/NFD. However, due to recent studies, the association is so strong that both the FDA and the company that makes gadodiamide have sent out warnings about the use of gadolinum-containing contrast in patients with advanced kidney disease. In view of
